Effectiveness of Kinesio Taping as an Adjunct to Conservative Treatment in Women With Lipedema
Effectiveness of Kinesio Taping as an Adjunct to Conservative Treatment in Women With Stage II Lipedema: A Prospective, Randomized Controlled Trial
This prospective, randomized controlled trial aims to evaluate the effectiveness of kinesio taping as an adjunct to standard conservative treatment in women with stage II lower-extremity lipedema.
A total of 30 women will be randomly assigned to two groups: a control group receiving standard conservative treatment and an intervention group receiving kinesio taping in addition to standard conservative treatment. Both groups will receive patient education, physical activity recommendations, and a standardized home exercise program. The intervention group will additionally receive bilateral lower-extremity kinesio taping twice weekly for six weeks.
Participants will be assessed at baseline, week 6 (end of treatment), and week 10 (four-week follow-up). The primary outcome will be the change in pain intensity measured using the Visual Analog Scale (VAS) at week 6. Secondary outcomes will include lower-extremity functional status (LEFS), quality of life (EQ-5D-3L), walking performance (4-meter walk test), lower-extremity circumference measurements, and pressure pain threshold assessed using an algometer.
The study aims to determine whether adding kinesio taping to standard conservative treatment provides additional clinical benefits in women with lipedema.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Hatice Zehra FERHATLAR
- 電話番号：05367387869
- メール：haticezehraferhatlar@gmail.com
研究場所
-
-
Istanbul
-
Küçükçekmece、Istanbul、トルコ（Türkiye）、34307
- 募集
- Kanuni Sultan Suleyman Training and Research Hospital
-
コンタクト：
- Hatice Zehra FERHATLAR, MD
- 電話番号：05367387869
- メール：haticezehraferhatlar@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
**Inclusion Criteria:**
- Female participants aged 18-65 years.
- Clinical diagnosis of stage II bilateral lower-extremity lipedema.
- Ability to walk independently.
- Ability and willingness to comply with the treatment and assessment schedule throughout the study.
- Provision of written informed consent.
**Exclusion Criteria:**
- Presence of primary or secondary lymphedema or lipolymphedema.
- Pregnancy or breastfeeding.
- Active infection, cellulitis, open wounds, or active dermatological disease in the areas where kinesio taping will be applied.
- Known allergy or hypersensitivity to kinesio tape or its adhesive components.
- Active deep vein thrombosis or thromboembolic disease.
- Severe neurological, rheumatological, or orthopedic disorders that may significantly affect lower-extremity function or walking performance.
- Severe cardiac, renal, or hepatic failure.
- Lipedema-related surgery or liposuction within the previous three months.
- Concurrent participation in another intensive physical therapy or manual lymphatic drainage program that may affect study outcomes.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Conservative Treatment + Kinesio Taping
|
Kinesio taping will be applied bilaterally to the lower extremities of participants in the experimental group twice weekly for six weeks, for a total of 12 applications. Kinesio taping will be administered in addition to standard conservative treatment. Standard conservative treatment will consist of patient education regarding lipedema and symptom management, physical activity recommendations, and a standardized lower-extremity home exercise program. This treatment will be provided to participants in both groups during the six-week intervention period. |
|
アクティブコンパレータ：Conservative Treatment Alone
|
Standard conservative treatment will consist of patient education regarding lipedema and symptom management, physical activity recommendations, and a standardized lower-extremity home exercise program. This treatment will be provided to participants in both groups during the six-week intervention period. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Pain Intensity Measured by the Visual Analog Scale (VAS)
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change in Lower Extremity Functional Scale (LEFS) Score
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
|
Change in Health-Related Quality of Life Measured by EQ-5D-3L
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
|
Change in Walking Performance Assessed by the 4-Meter Walk Test
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
|
Change in Lower Extremity Circumference Measurements
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
|
Change in Pressure Pain Threshold (PPT) Measured by Algometry
時間枠：Baseline (week 0), week 6, and week 10
|
Baseline (week 0), week 6, and week 10
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Michelini S, Musa F, Vetrano M, Santoboni F, Nusca SM, Latini E, Trischitta D, Michelini S, Iosa M, Vulpiani MC. Defocused and Radial Shock Wave Therapy, Mesotherapy, and Kinesio Taping Effects in Patients with Lipedema: A Pilot Study. Lymphology. 2023;56(1):13-26.
- Rio-Gonzalez A, Delgado-Perez E, Garcia-Garcia E, Gonzalez-Fernandez L, Garcia-Isidoro S, Cerezo-Tellez E. Physiotherapy Intervention in the Immediate Postoperative Phase of Lipedema Surgery-Observational Study. J Clin Med. 2025 Mar 21;14(7):2137. doi: 10.3390/jcm14072137.
- Fetzer A. Specialist approaches to managing lipoedema. Br J Community Nurs. 2016 Apr;Suppl:S30-5. doi: 10.12968/bjcn.2016.21.Sup4.S30.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- LIPE-KT-2026
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。